Novel agents inhibit human leukemic cells.
Department of Pathophysiology, Medical School of Southeast University, Nanjing, China. wpylg@hotmail.com
Wei-ping
WP
Yu
Juan
J
Li
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009942:Organometallic Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D010042:Ouabain / Q000494:pharmacology / Q000627:therapeutic use*; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D002316:Cardiotonic Agents; D009942:Organometallic Compounds; D011725:Pyridines; D010042:Ouabain; C010423:pyrithione zinc